CFDA-话题@MedSci

#CFDA#

184篇内容 | 3712人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890702, encodeId=253a1890e02a7, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA发布声明！要求修改钆对比剂说明书, objectType=article, longId=127778, objectId=db4312e7782e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db4312e7782e, replyNumber=0, likeNumber=72, createdTime=2018-12-29, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db4312e7782e, moduleTitle=CFDA发布声明！要求修改钆对比剂说明书, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db4312e7782e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890650, encodeId=b45818906507a, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA局长毕井泉：药品标准的极端重要！, objectType=article, longId=112272, objectId=338e1122e258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=338e1122e258, replyNumber=0, likeNumber=87, createdTime=2018-06-13, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=338e1122e258, moduleTitle=CFDA局长毕井泉：药品标准的极端重要！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=338e1122e258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890692, encodeId=04d01890692b1, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：立案调查29药企, objectType=article, longId=125156, objectId=0327125156d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0327125156d0, replyNumber=0, likeNumber=72, createdTime=2018-03-19, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0327125156d0, moduleTitle=CFDA：立案调查29药企, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0327125156d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890630, encodeId=c22b18906301e, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA严令：24项措施“大整顿”违规违法严查严办!, objectType=article, longId=99498, objectId=d45a9949810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d45a9949810, replyNumber=0, likeNumber=56, createdTime=2017-12-21, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d45a9949810, moduleTitle=CFDA严令：24项措施“大整顿”违规违法严查严办!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d45a9949810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890662, encodeId=df3d189066223, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：36条政策意见“具有里程碑意义”, objectType=article, longId=115618, objectId=644411561892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644411561892, replyNumber=0, likeNumber=58, createdTime=2018-06-29, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644411561892, moduleTitle=CFDA：36条政策意见“具有里程碑意义”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=644411561892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890670, encodeId=cc6d18906e053, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=勃林格殷格翰泰毕全®（达比加群酯）新适应症获CFDA批准, objectType=article, longId=121092, objectId=76a6121092e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76a6121092e6, replyNumber=0, likeNumber=64, createdTime=2017-11-27, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76a6121092e6, moduleTitle=勃林格殷格翰泰毕全®（达比加群酯）新适应症获CFDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76a6121092e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890667, encodeId=49bb189066e48, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA发文：加强互联网药品医疗器械交易监管, objectType=article, longId=118673, objectId=ab1e1186e357, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab1e1186e357, replyNumber=0, likeNumber=97, createdTime=2018-09-13, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab1e1186e357, moduleTitle=CFDA发文：加强互联网药品医疗器械交易监管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab1e1186e357)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890679, encodeId=755918906e91d, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA批准上市泰瑞沙®（甲磺酸奥希替尼片）审评概述，用于非小细胞性肺癌(NSCLC)成人患者的治疗, objectType=article, longId=122001, objectId=be1312200102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be1312200102, replyNumber=0, likeNumber=70, createdTime=2017-12-09, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be1312200102, moduleTitle=CFDA批准上市泰瑞沙®（甲磺酸奥希替尼片）审评概述，用于非小细胞性肺癌(NSCLC)成人患者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be1312200102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890686, encodeId=a3f81890686bb, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA又飞检：两医械公司停产整顿, objectType=article, longId=124068, objectId=507b12406851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507b12406851, replyNumber=0, likeNumber=51, createdTime=2018-09-26, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507b12406851, moduleTitle=CFDA又飞检：两医械公司停产整顿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=507b12406851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890671, encodeId=31bf18906e147, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA批准上市口服多激酶抑制剂——Stivarga®（瑞戈非尼）审评概述，用于转移性结直肠癌患者, objectType=article, longId=121648, objectId=f3ab12164873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3ab12164873, replyNumber=0, likeNumber=92, createdTime=2018-10-12, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3ab12164873, moduleTitle=CFDA批准上市口服多激酶抑制剂——Stivarga®（瑞戈非尼）审评概述，用于转移性结直肠癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3ab12164873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890672, encodeId=54d018906e236, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA批准上市安达唐®（达格列净片）审评概述，用于2型糖尿病成年患者的血糖控制, objectType=article, longId=121650, objectId=62141216505e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62141216505e, replyNumber=0, likeNumber=77, createdTime=2017-12-27, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62141216505e, moduleTitle=CFDA批准上市安达唐®（达格列净片）审评概述，用于2型糖尿病成年患者的血糖控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62141216505e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890635, encodeId=9d4b18906354c, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA连发12条人事变动公告涉副局长等24职位, objectType=article, longId=101440, objectId=8b3f10144032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b3f10144032, replyNumber=0, likeNumber=102, createdTime=2018-03-17, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b3f10144032, moduleTitle=CFDA连发12条人事变动公告涉副局长等24职位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b3f10144032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890656, encodeId=ff2f1890656eb, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=多位CFDA官员解读上市许可持有人制度, objectType=article, longId=114464, objectId=2e6e1144644d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6e1144644d, replyNumber=0, likeNumber=61, createdTime=2018-06-22, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6e1144644d, moduleTitle=多位CFDA官员解读上市许可持有人制度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e6e1144644d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890682, encodeId=a63c189068250, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA公布6项医疗器械行业标准， 2018年12月1日起实施, objectType=article, longId=123282, objectId=53e7123282d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53e7123282d5, replyNumber=0, likeNumber=58, createdTime=2018-04-19, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53e7123282d5, moduleTitle=CFDA公布6项医疗器械行业标准， 2018年12月1日起实施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53e7123282d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890626, encodeId=609d1890626fc, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA公告：8家械企产品抽检不符规定, objectType=article, longId=98266, objectId=151a9826630, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=151a9826630, replyNumber=0, likeNumber=78, createdTime=2018-03-12, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=151a9826630, moduleTitle=CFDA公告：8家械企产品抽检不符规定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=151a9826630)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890665, encodeId=bb59189066529, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=备案制细则来了！CFDA发布《药物临床试验机构管理规定（征求意见稿）》, objectType=article, longId=117851, objectId=368011e85118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=368011e85118, replyNumber=0, likeNumber=89, createdTime=2018-05-20, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=368011e85118, moduleTitle=备案制细则来了！CFDA发布《药物临床试验机构管理规定（征求意见稿）》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=368011e85118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890668, encodeId=63ef18906680f, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA公布《网络药品经营监督管理办法(征求意见稿)》, objectType=article, longId=120113, objectId=ac9712011379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac9712011379, replyNumber=0, likeNumber=53, createdTime=2018-05-20, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac9712011379, moduleTitle=CFDA公布《网络药品经营监督管理办法(征求意见稿)》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac9712011379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890655, encodeId=adb71890655f2, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA司长：GMP/GSP等认证全取消！, objectType=article, longId=114427, objectId=dac911442ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dac911442ea8, replyNumber=0, likeNumber=55, createdTime=2017-11-20, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dac911442ea8, moduleTitle=CFDA司长：GMP/GSP等认证全取消！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dac911442ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890683, encodeId=3fec1890683b3, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA提示，要关注反复使用核磁共振对比剂引起脑部钆沉积的风险, objectType=article, longId=123458, objectId=fc57123458f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc57123458f5, replyNumber=0, likeNumber=69, createdTime=2018-02-21, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc57123458f5, moduleTitle=CFDA提示，要关注反复使用核磁共振对比剂引起脑部钆沉积的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc57123458f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890654, encodeId=91061890654ce, content=<a href='/topic/show?id=a867452008' target=_blank style='color:#2F92EE;'>#CFDA#</a>, objectTitle=CFDA：冬虫夏草不再属于保健品, objectType=article, longId=113582, objectId=f405113582fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f405113582fd, replyNumber=0, likeNumber=64, createdTime=2018-05-20, rootId=0, userName=stfoxst, userId=1a19115, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f405113582fd, moduleTitle=CFDA：冬虫夏草不再属于保健品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f405113582fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CFDA

2020-05-29

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA发布声明！要求修改钆对比剂说明书

2018-12-29

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA局长毕井泉：药品标准的极端重要！

2018-06-13

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：立案调查29药企

2018-03-19

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA严令：24项措施“大整顿”违规违法严查严办!

2017-12-21

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：36条政策意见“具有里程碑意义”

2018-06-29

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

勃林格殷格翰泰毕全®（达比加群酯）新适应症获CFDA批准

2017-11-27

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA发文：加强互联网药品医疗器械交易监管

2018-09-13

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA批准上市泰瑞沙®（甲磺酸奥希替尼片）审评概述，用于非小细胞性肺癌(NSCLC)成人患者的治疗

2017-12-09

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA又飞检：两医械公司停产整顿

2018-09-26

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA批准上市口服多激酶抑制剂——Stivarga®（瑞戈非尼）审评概述，用于转移性结直肠癌患者

2018-10-12

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA批准上市安达唐®（达格列净片）审评概述，用于2型糖尿病成年患者的血糖控制

2017-12-27

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA连发12条人事变动公告涉副局长等24职位

2018-03-17

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

多位CFDA官员解读上市许可持有人制度

2018-06-22

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA公布6项医疗器械行业标准， 2018年12月1日起实施

2018-04-19

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA公告：8家械企产品抽检不符规定

2018-03-12

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

备案制细则来了！CFDA发布《药物临床试验机构管理规定（征求意见稿）》

2018-05-20

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA公布《网络药品经营监督管理办法(征求意见稿)》

2018-05-20

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA司长：GMP/GSP等认证全取消！

2017-11-20

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA提示，要关注反复使用核磁共振对比剂引起脑部钆沉积的风险

2018-02-21

stfoxst (审核中...)

前往app查看评论内容

#CFDA#

CFDA：冬虫夏草不再属于保健品

2018-05-20

科室
- - 订阅+
  - 更多科室
工具
服务